StudyRareStudyRare

Methionine and homocysteine metabolism

Log in to star
Amino acid metabolism

Last updated Nov 15, 2026

Log in to add personal notes on this page.

Methionine becomes S-adenosylmethionine, then S-adenosylhomocysteine, then homocysteine, the three steps of methionine transmethylation. Homocysteine then has two exits. Remethylation turns it back into methionine, closing the methionine cycle, using a folate methyl group and a vitamin B12 coenzyme; transsulfuration turns it into cystathionine and then cysteine, using vitamin B6. Further down, cysteine and methionine sulfur is oxidized to sulfate. Homocysteine itself is toxic, so a block at either exit raises it, and the methionine level tells you which exit is shut.

methionine adenosyltransferaseI/IIIMAT1Amethyltransferases, among themglycine N-methyltransferaseGNMTS-adenosylhomocysteinehydrolaseAHCYcystathionine beta-synthaseCBS; pyridoxal 5'-phosphate(B6); with serine; the firstirreversible step oftranssulfurationhomocystinuriacystathionasecysteine then makesglutathione and othersulfur-containing moleculesoxidative cysteine breakdownsulfite oxidaseSUOX; molybdenum cofactor,built by MOCS1, MOCS2,GPHN, MOCS3secondary: molybdenum cofactordeficiencymethionine synthaseMTR; methylcobalamin (B12);with 5-methyltetrahydrofolate,made by MTHFR; a secondroute: betaine homocysteinemethyltransferasecobalamin E and G deficiency(MTR, MTRR)secondary: cobalamin Cdeficiency (MMACHC)secondary: MTHFR variants(partly slowed)methionineS-adenosylmethionineS-adenosylhomocysteinehomocysteinecystathioninecysteinesulfitesulfate
Figure: the methionine cycle, from methionine through S-adenosylmethionine and S-adenosylhomocysteine to homocysteine and back to methionine by remethylation, with transsulfuration leaving homocysteine for sulfate; CBS deficiency and cobalamin E and G deficiency are at their own enzymes, and the two cofactor defects and the common folate-enzyme variant are at the steps they affect.
  1. methionine → S-adenosylmethionine: methionine adenosyltransferase I/III (MAT1A).
  2. S-adenosylmethionine → S-adenosylhomocysteine: the methyltransferases, among them glycine N-methyltransferase (GNMT).
  3. S-adenosylhomocysteine → homocysteine: S-adenosylhomocysteine hydrolase (AHCY).
  4. 5,10-methylenetetrahydrofolate → 5-methyltetrahydrofolate: methylenetetrahydrofolate reductase (MTHFR), which makes the folate cofactor for the next step. Partly slowed by the common MTHFR variants.
  5. homocysteine + 5-methyltetrahydrofolate → methionine: methionine synthase (MTR), which needs methylcobalamin, a vitamin B12 coenzyme. This closes the cycle. Methylcobalamin runs short in cobalamin C deficiency, a defect of cofactor processing. The MMACHC protein, which processes cobalamin for both B12 coenzymes, is the one deficient, not methionine synthase itself. Blocked in cobalamin E and G deficiency: cblG at methionine synthase itself, cblE at methionine synthase reductase (MTRR), which keeps the enzyme active. How cobalamin reaches this enzyme, and every disorder along that route, is on cobalamin transport and processing. Betaine offers a second route from homocysteine back to methionine, through betaine homocysteine methyltransferase.
  6. homocysteine + serine → cystathionine: cystathionine beta-synthase (CBS), the first irreversible step of transsulfuration, with pyridoxal 5'-phosphate (vitamin B6). Blocked in homocystinuria.
  7. cystathionine → cysteine: cystathionase, the enzyme that supplies the body's own cysteine. Cysteine is a precursor for glutathione and other sulfur-containing molecules.
  8. cysteine → sulfite: oxidative cysteine breakdown.
  9. sulfite → sulfate: sulfite oxidase (SUOX), the last step of methionine and cysteine breakdown, which needs the molybdenum cofactor built by MOCS1, MOCS2, GPHN, and MOCS3. Its activity is lost in molybdenum cofactor deficiency, a defect of cofactor synthesis rather than of sulfite oxidase itself.
  • Homocystinuria (CBS deficiency): homocysteine and methionine rise and cysteine falls. Homocysteine damages connective tissue cross-links and endothelium, giving lens dislocation, a tall Marfan-like build, and thromboembolism. About half respond to vitamin B6, which helps the mutant enzyme fold and work.
  • Cobalamin C deficiency: a cofactor defect, not a deficiency of either enzyme. The MMACHC protein that processes cobalamin is deficient, so both B12 coenzymes run short. Methionine synthase then fails secondarily (homocysteine up, methionine low or normal), and so does methylmalonyl-CoA mutase (methylmalonic acid up). It belongs to the propionate pathway as well.
  • Cobalamin E and G deficiency: methionine synthase (cblG) or its reductase (cblE) fails. Homocysteine rises and methionine falls, with normal methylmalonic acid. Folate is trapped as 5-methyltetrahydrofolate, which gives megaloblastic anemia, and infants also have hypotonia, developmental delay, and seizures.
  • MTHFR variants: the common c.677C>T variant (c.665C>T on the current transcript) makes a heat-labile enzyme. Homozygotes tend to have higher homocysteine and lower serum folate, mainly when folate intake is low. It does not cause homocystinuria and is not a thrombophilia.
  • Molybdenum cofactor deficiency: the molybdenum cofactor is not made, so sulfite oxidase fails secondarily and sulfite cannot become sulfate. Sulfite and S-sulfocysteine build up and injure the brain, giving early refractory seizures; xanthine oxidase also fails, so uric acid is low.
  • Also on this pathway, without a page here yet: the hypermethioninemias of the first three steps, MAT I/III deficiency (MAT1A), GNMT deficiency (GNMT), and S-adenosylhomocysteine hydrolase deficiency (AHCY), all with high methionine and normal or only slightly raised total homocysteine; severe MTHFR deficiency (high homocysteine, low methionine, no megaloblastic anemia); and isolated sulfite oxidase deficiency (like molybdenum cofactor deficiency, but with normal uric acid).
  • Total homocysteine with methionine names the exit. High homocysteine with high methionine is CBS deficiency, because homocysteine cannot leave by transsulfuration and methionine accumulates with it. High homocysteine with low or normal methionine is a remethylation defect (MTHFR deficiency or a cobalamin defect), because methionine cannot be made back. High methionine with normal or only slightly raised homocysteine points above homocysteine, to a transmethylation defect (MAT I/III, GNMT, or S-adenosylhomocysteine hydrolase deficiency), or to liver disease such as tyrosinemia type I. Newborn screening measures methionine, not homocysteine, in most programs: a high methionine flags CBS deficiency, and some programs flag a low methionine, which with a high homocysteine on follow-up points to severe MTHFR deficiency. Because the screen reads methionine, a remethylation defect can be missed, and infants with B6-responsive CBS deficiency often lack a high methionine in the first days of life, so a child with the features is tested anyway.
  • Methylmalonic acid is raised in cobalamin C deficiency and normal in CBS deficiency, MTHFR deficiency, and cblE and cblG, because only a defect above the cobalamin branch point also starves methylmalonyl-CoA mutase.
  • Megaloblastic anemia separates the cobalamin remethylation defects (cblE, cblG, cblC) from MTHFR deficiency, which lacks it.
  • Low homocysteine and low uric acid with urinary S-sulfocysteine point to molybdenum cofactor deficiency; uric acid is normal in isolated sulfite oxidase deficiency.